Biochemical and Biophysical Research Communications, Vol.295, No.1, 129-135, 2002
Cloning a cDNA encoding an alternatively spliced protein of BRCA2-associated factor 35
Inheritance of mutations in the breast cancer susceptibility gene, BRCA2, predisposes humans to breast and ovarian cancers. Inherited mutations in the BRCA2 gene are also known to cause susceptibility to prostate cancer. BRCA2 protein exists in a large multi-protein complex from which a novel structural DNA binding protein BRCA2-associated factor 35 (BRAF35) has been isolated. Vie have cloned a novel cDNA encoding an alternatively spliced protein of BRAF35, designated as BRAF25. BRAF25 transcript is present in various human cells. We have precisely mapped the BRAF25 cDNA sequence to the genomic chromosome 19 sequence. Analysis of the predicted sequence of BRAF25 identified a protein of 215 amino acids. BRAF25 contains a truncated high mobility group domain, a kinesin-like coiled-coil domain and multiple Src homology 2 (SH2) motifs. Western blot analysis using antibodies specific for BRAF25 revealed the presence of BRAF25 in human prostate cancer cells. (C) 2002 Elsevier Science (USA). All rights reserved.
Keywords:BRCA2 complex;cancer predisposition;breast cancer;ovarian cancer;prostate cancer;alternatively spliced BRAF25 protein;truncated HMG domain;chromosome 19;immunoprecipitation